New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Asklepios Kliniken · ISIN: DE000A0ETLQ3 · EQS - Company News (29 News)
Country: Germany · Primary market: Germany · EQS NID: 1572697
02 March 2023 10:00AM

Asklepios Kliniken: Group-wide ESG strategy


EQS-News: Asklepios Kliniken / Key word(s): ESG/Sustainability
Asklepios Kliniken: Group-wide ESG strategy

02.03.2023 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Asklepios Kliniken: Group-wide ESG strategy

Hamburg, 2 March 2023. Asklepios Kliniken GmbH & Co. KGaA has adopted a Group-wide ESG strategy on the basis of successful groundwork. In addition to environmental issues, the strategy also covers social and governance aspects, which are equally important for a healthcare group.

As a large healthcare group, Asklepios has particular responsibility for environmental, social and governance issues. For the past five years, Asklepios has therefore been preparing a voluntary Corporate Responsibility Report that meets the requirements under the German Corporate Code (CSR RUG) and is based on the standards of the Global Reporting Initiative (GRI standards). The necessary structures to integrate the topic of corporate responsibility in the Group have been established and continuously optimised. Following successful groundwork in the area of ESG and sustainability, the results were summarised in a Group-wide ESG strategy and adopted by the Management Board in the fourth quarter of 2022.

The ESG strategy comprises seven key topics: Asklepios is aiming to cut CO2 emissions (Scope 1 and 2) by up to 45,000 tons by 2030 and plans to operate on a climate-neutral basis by 2040. A reduction in both waste volumes and water consumption in relation to the number of patients is targeted by 2030. With regard to social issues, there will be a particular focus on employee health, patient safety and patient satisfaction. The governance aspect focuses on strengthening and complying with Asklepios’s rules of conduct.

For strategic reasons, it has been decided to expand and reallocate the tasks of the Group ESG & Sustainability department – particularly in view of the upcoming reporting regulations as well as the EU Taxonomy and the Corporate Sustainability Reporting Directive (CSRD). To this end, ESG reporting will be bundled with financial reporting in the Group Reporting staff unit as an interdisciplinary task for which Mirjam Constantin will be responsible. The Group ESG & Sustainability department, which focuses on the further development and operational implementation of the sustainability strategy, is to be expanded and will be headed by Aline Mittag.

Overall responsibility for the ESG strategy lies with the Management Board, while strategic sustainability management is the task of the ESG Board, which acts as the decision-making body and is responsible for designing and organising the corporate responsibility roadmap. The CR roadmap addresses the seven key topics for Asklepios. Responsibility for the operational implementation of the CR roadmap lies with the healthcare facilities. The Group ESG department manages the key objectives and is responsible for implementing the necessary measures.

About Asklepios
Asklepios Kliniken is one of the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly qualified care for its patients, with a clear commitment to medical quality, innovation and social responsibility. On this basis, Asklepios has been developing dynamically since it was founded over 35 years ago. The Group currently has around 170 healthcare facilities throughout Germany. These include acute care hospitals of all different care levels, university hospitals, specialist clinics, psychiatric facilities, forensic institutions, rehabilitation clinics, nursing homes and medical centres. In the 2021 financial year, over 3.5 million patients were treated at the Asklepios Group’s facilities. The company has more than 67,000 employees.

IR contact
Mirjam Constantin
Head of Group Reporting (Financial & ESG)/ Manager Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 - 61462 Königstein-Falkenstein
Tel.: +49 61 74 90-1166
Fax: +49 61 74 90-1110
ir@asklepios.com

PR contact
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226 - 22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639 
presse@asklepios.com

Visit Asklepios online, on Facebook or on YouTube:
www.asklepios.com
gesundleben.asklepios.com
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken



02.03.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


1572697  02.03.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1572697&application_name=news&site_id=boersengefluester_html

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.